References
- All references listed with a * refer to studies included in the meta-analysis.
- *Åberg-Wistedt, A., Ågren, H., Ekselius, L., Bengtson, F., & Åkerblad, A. (2000). Sertraline versus paroxetine in major depression: Clinical outcome after six months of continuous therapy. Journal of Clinical Psychopharmacology, 20, 645–652. http://dx.doi.org/10.1097/00004714-200012000-00010 10.1097/00004714-200012000-00010
- *Almlöv, J., Carlbring, P., Berger, T., Cuijpers, P., & Andersson, G. (2009). Therapist factors in internet-delivered cognitive behavioural therapy for major depressive disorder. Cognitive Behaviour Therapy, 38, 247–254. http://dx.doi.org/10.1080/16506070903116935
- Angermeyer, M. C., & Katschnig, H. (2006). Psychotropic medication and quality of life: A conceptual framework for assessing their relationship. In H. Katschnig, H. Freeman, & N. Sartorius (Eds.), Quality of life in mental disorders (2nd ed., pp. 215–225). New York, NY: Wiley.
- Angermeyer, M. C., & Kilian, R. (2006). Theoretical models of quality of life for mental disorders. In H. Katschnig, H. Freeman, & N. Sartorius (Eds.), Quality of life in mental disorders (2nd ed., pp. 21–31). New York, NY: Wiley.
- Armijo-Olivo, S., Stiles, C. R., Hagen, N. A., Biondo, P. D., & Cummings, G. G. (2012). Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: Methodological research. Journal of Evaluation in Clinical Practice, 18, 12–18. http://dx.doi.org/10.1111/j.1365-2753.2010.01516.x 10.1111/jep.2012.18.issue-1
- Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Beck depression inventory-II manual. San Diego, CA: Harcourt Brace Jovonovich.
- Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571. http://dx.doi.org/10.1001/archpsyc.1961.01710120031004 10.1001/archpsyc.1961.01710120031004
- *Bellino, S., Zizza, M., Rinaldi, C., & Bogetto, F. (2006). Combined treatment of major depression in patients with borderline personality disorder: A comparison with pharmacotherapy. The Canadian Journal of Psychiatry, 51, 453–460. http://dx.doi.org/10.1177/070674370605100707 10.1177/070674370605100707
- *Brothers, B., Yang, H., Strunk, D., & Andersen, B. (2011). Cancer patients with major depressive disorder: Testing a biobehavioral/cognitive behavior intervention. Journal of Consulting and Clinical Psychology, 79, 253–260. http://dx.doi.org/10.1037/a0022566 10.1037/a0022566
- Comprehensive Meta-Analysis (Version 3) [Computer software]. (2015). Englewood, NJ: Biostat. Retrieved from https://www.meta-analysis.com/
- *Craigie, M., & Nathan, P. (2009). A nonrandomized effectiveness comparison of broad-spectrum group CBT to individual CBT for depressed outpatients in a community mental health setting. Behavior Therapy, 40, 302–314. http://dx.doi.org/10.1016/j.beth.2008.08.002 10.1016/j.beth.2008.08.002
- *Craigie, M., Saulsman, L., & Lampard, A. (2007). MCMI-III personality complexity and depression treatment outcome following group-based cognitive-behavioral therapy. Journal of Clinical Psychology, 63, 1153–1170. http://dx.doi.org/10.1002/(ISSN)1097-4679 10.1002/(ISSN)1097-4679
- Cristea, I. A., Huibers, M. J., David, D., Hollon, S. D., Andersson, G., & Cuijpers, P. (2015). The effects of cognitive behavior therapy for adult depression on dysfunctional thinking: A meta-analysis. Clinical Psychology Review, 42, 62–71. http://dx.doi.org/10.1016/j.cpr.2015.08.003 10.1016/j.cpr.2015.08.003
- Cuijpers, P., Li, J., Hofmann, S. G., & Andersson, G. (2010). Self-reported versus clinician-rated symptoms of depression as outcome measures in psychotherapy research on depression: A meta-analysis. Clinical Psychology Review, 30, 768–778. http://dx.doi.org/10.1016/j.cpr.2010.06.001 10.1016/j.cpr.2010.06.001
- *Demyttenaere, K., Andersen, H., & Reines, E. (2008). Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder. International Clinical Psychopharmacology, 23, 276–286. http://dx.doi.org/10.1097/YIC.0b013e328303ac5f 10.1097/YIC.0b013e328303ac5f
- Derogatis, L. R. (2000). Symptom Checklist-90-Revised (SCL-90-R) [Self-report measure]. In J. A. Rush (Ed.), Task force for the handbook of psychiatric measures. Handbook of psychiatric measures (pp. 81–84). Washington, DC: American Psychiatric Association.
- *Dobkin, R. D., Menza, M., Allen, L. A., Gara, M. A., Mark, M. H., Tiu, J., … Friedman, J. (2011). Cognitive-behavioral therapy for depression in Parkinson’s disease: A randomized, controlled trial. American Journal of Psychiatry, 168, 1066–1074. http://dx.doi.org/10.1176/appi.ajp.2011.10111669 10.1176/appi.ajp.2011.10111669
- Duval, S., & Tweedie, R. (2000). Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56, 455–463. http://dx.doi.org/10.1111/j.0006-341X.2000.00455.x 10.1111/j.0006-341X.2000.00455.x
- Endicott, J., Nee, J., Harrison, W., & Blumenthal, R. (1993). Quality of Life Enjoyment and Satisfaction Questionnaire: A new measure. Psychopharmacological Bulletin, 29, 321–326.
- Farabaugh, A., Fisher, L., Nyer, M., Holt, D., Cohen, M., Baer, L., … Alpert, J. E. (2015). Similar changes in cognitions following cognitive-behavioral therapy or escitalopram for major depressive disorder: Implications for mechanisms of change. Annals of Clinical Psychiatry, 27, 118–125.
- *Freedland, K. E., Skala, J. A., Carney, R. M., Rubin, E. H., Lustman, P. J., Dávila-Román, V. G., … Hogue Jr., C. R. (2009). Treatment of depression after coronary artery bypass surgery. Archives of General Psychiatry, 66, 387–396. http://dx.doi.org/10.1001/archgenpsychiatry.2009.7 10.1001/archgenpsychiatry.2009.7
- Frisch, M. B., Clark, M. P., Rouse, S. V., Rudd, M. D., Paweleck, J. K., Greenstone, A., & Kopplin, D. A. (2005). Predictive and treatment validity of life satisfaction and the Quality of Life Inventory. Assessment, 12, 66–78. http://dx.doi.org/10.1177/1073191104268006 10.1177/1073191104268006
- Gelenberg, A. J., Freeman, M. P., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Van Rhoads, R. S. (2010). Practice guideline for the treatment of patients with major depressive disorder (3rd ed.). Retrieved from http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf.
- Gladis, M. M., Gosch, E. A., Dishuk, N. M., & Crits-Christoph, P. (1999). Quality of life: Expanding the scope of clinical significance. Journal of Consulting and Clinical Psychology, 67, 320–331. http://dx.doi.org/10.1037/0022-006X.67.3.320 10.1037/0022-006X.67.3.320
- *Gleason, O., Yates, W., Isbell, M., & Philipsen, M. (2002). An open-label trial of citalopram for major depression in patients with hepatitis C. The Journal of Clinical Psychiatry, 63, 194–198. http://dx.doi.org/10.4088/JCP.v63n0304 10.4088/JCP.v63n0304
- Gorman, J. M., & Kent, J. M. (1999). SSRIs and SNRIs: Broad spectrum of efficacy beyond major depression. Journal of Clinical Psychiatry, 60, 33–39.
- Greenberg, P. E., Fournier, A. A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015). The economic burden of adults with major depressive disorder in the United States (2005 and 2010). The Journal of Clinical Psychiatry, 76, 155–162. http://dx.doi.org/10.4088/JCP.14m09298 10.4088/JCP.14m09298
- Hamilton, M. (1960). A rating scale for depression. Journal of Neurology Neurosurgery & Psychiatry, 23, 54–62. http://dx.doi.org/10.1136/jnnp.23.1.56
- Hays, R., Sherbourne, C., & Mazel, R. (1993). The RAND 36-Item Health Survey 1.0. Health Economics, 2, 217–227. http://dx.doi.org/10.1002/(ISSN)1099-1050 10.1002/(ISSN)1099-1050
- Hedges, L., & Olkin, I. (1985). Statistical methods for meta-analysis. Amsterdam: Academic Press.
- Higgins, J., & Altman, D. G. (2008). Chapter 8: Assessing risk of bias in included studies. In J. Higgins & S. Green (Eds.), Cochrane handbook for systematic reviews of interventions version 5.0. Retrieved from http://www.cochrane-handbook.org. http://dx.doi.org/10.1002/9780470712184 10.1002/9780470712184
- Higgins, J. P., & Green, S. (Eds.). (2011). Cochrane handbook for systematic reviews of interventions version 5.1.0. Retrieved from http://www.cochrane-handbook.org
- Hirschfeld, R. M., Dunner, D. L., Keitner, G., Klein, D. N., Koran, L. M., Kornstein, S. G., … Keller, M. B. (2002). Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biological Psychiatry, 51, 123–133. http://dx.doi.org/10.1016/S0006-3223(01)01291-4 10.1016/S0006-3223(01)01291-4
- Hofmann, S. G., Asnaani, A., Vonk, I. J. J., Sawyer, A. T., & Fang, A. (2012). The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognitive Therapy and Research, 36, 427–440. http://dx.doi.org/10.1007/s10608-012-9476-1 10.1007/s10608-012-9476-1
- Hofmann, S. G., Wu, J. Q., & Boettcher, H. (2014). Effect of cognitive-behavioral therapy for anxiety disorders on quality of life: A meta-analysis. Journal of Consulting and Clinical Psychology, 82, 375. http://dx.doi.org/10.1007/s10608-012-9476-1 10.1037/a0035491
- Hofmann, S. G., Wu, J. Q., Boettcher, H., & Sturm, J. (2014). Effect of pharmacotherapy for anxiety disorders on quality of life: A meta-analysis. Quality of Life Research, 23, 1141–1153. http://dx.doi.org/10.1007/s11136-013-0573-8 10.1007/s11136-013-0573-8
- *Hopko, D. R., Armento, M. E., Robertson, S., Ryba, M. M., Carvalho, J. P., Colman, L. K., … Lejuez, C. W. (2011). Brief behavioral activation and problem-solving therapy for depressed breast cancer patients: Randomized trial. Journal of Consulting and Clinical Psychology, 79, 834–849. http://dx.doi.org/10.1037/a0025450 10.1037/a0025450
- *Hopko, D. R., Bell, J. L., Armento, M., Robertson, S., Mullane, C., Wolf, N., & Lejuez, C. W. (2008). Cognitive-behavior therapy for depressed cancer patients in a medical care setting. Behavior Therapy, 39, 126–136. http://dx.doi.org/10.1016/j.beth.2007.05.007 10.1016/j.beth.2007.05.007
- Ioannidis, J. P. (2005). Contradicted and initially stronger effects in highly cited clinical research. JAMA, 294, 218–228. http://dx.doi.org/10.1001/jama.294.2.218 10.1001/jama.294.2.218
- *IsHak, W. W., Christensen, S., Sayer, G., Ha, K., Li, N., Miller, J., … Cohen, R. M. (2013). Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study. The Journal of Clinical Psychiatry, 74, 256–261. http://dx.doi.org/10.4088/JCP.12m07933 10.4088/JCP.12m07933
- *Jha, M. K., Minhajuddin, A., Thase, M. E., & Jarrett, R. B. (2014). Improvement in self-reported quality of life with cognitive therapy for recurrent major depressive disorder. Journal of Affective Disorders, 167, 37–43. http://dx.doi.org/10.1016/j.jad.2014.05.038 10.1016/j.jad.2014.05.038
- *Johansson, R., Nyblom, A., Carlbring, P., Cuijpers, P., & Andersson, G. (2013). Choosing between Internet-based psychodynamic versus cognitive behavioral therapy for depression: A pilot preference study. BMC Psychiatry, 13, 268. http://dx.doi.org/10.1186/1471-244X-13-268 10.1186/1471-244X-13-268
- *Johansson, R., Sjöberg, E., Sjögren, M., Johnsson, E., Carlbring, P., Andersson, T., … Andersson, G. (2012). Tailored vs. standardized internet-based cognitive behavior therapy for depression and comorbid symptoms: A randomized controlled trial. Plos ONE, 7, e36905. http://dx.doi.org/10.1371/journal.pone.0036905
- Johnsen, T., & Friborg, O. (2015). The effects of cognitive behavioral therapy as an anti-depressive treatment is falling: A meta-analysis. Psychological Bulletin, 141, 747–768. http://dx.doi.org/10.1037/bul0000015
- Judd, L. L., Akiskal, H. S., Zeller, P. J., Paulus, M., Leon, A. C., Maser, J. D., … Keller, M. D. (2000). Psychosocial disability during the long-term course of unipolar major depressive disorder. Archives of General Psychiatry, 57, 375–380. http://dx.doi.org/10.1001/archpsyc.57.4.375 10.1001/archpsyc.57.4.375
- *Kanter, J. W., Santiago-Rivera, A. L., Santos, M. M., Nagy, G., López, M., Hurtado, G. D., & West, P. (2015). A randomized hybrid efficacy and effectiveness trial of behavioral activation for Latinos with depression. Behavior Therapy, 46, 177–192. http://dx.doi.org/10.1016/j.beth.2014.09.011 10.1016/j.beth.2014.09.011
- Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., … Wang, P. S. (2003). The epidemiology of major depressive disorder. JAMA, 289, 3095–3105. http://dx.doi.org/10.1001/jama.289.23.3095 10.1001/jama.289.23.3095
- Kolovos, S., Kleiboer, A., & Cuijpers, P. (2016). Effect of psychotherapy for depression on quality of life: Meta-analysis. The British Journal of Psychiatry, 209, 460–468. http://dx.doi.org/10.1192/bjp.bp.115.175059 10.1192/bjp.bp.115.175059
- Kroenke, K., Spitzer, R., & Williams, J. (2001). The PHQ-9. Journal of General Internal Medicine, 16, 606–613. http://dx.doi.org/10.1046/j.1525-1497.2001.016009606.x 10.1046/j.1525-1497.2001.016009606.x
- *Laidlaw, K., Davidson, K., Toner, H., Jackson, G., Clark, S., Law, J., … Cross, S. (2008). A randomised controlled trial of cognitive behaviour therapy vs treatment as usual in the treatment of mild to moderate late life depression. International Journal of Geriatric Psychiatry, 23, 843–850. http://dx.doi.org/10.1002/gps.v23:8 10.1002/gps.v23:8
- *Lemmens, L. H., Arntz, A., Peeters, F., Hollon, S. D., Roefs, A., & Huibers, M. J. (2015). Clinical effectiveness of cognitive therapy v. interpersonal psychotherapy for depression: Results of a randomized controlled trial. Psychological Medicine, 45, 2095–2110. http://dx.doi.org/10.1017/S0033291715000033 10.1017/S0033291715000033
- *Levin, W., Campbell, D., McGovern, K., Gau, J., Kosty, D., Seeley, J. R., & Lewinsohn, P. (2011). A computer-assisted depression intervention in primary care. Psychological Medicine, 41, 1373–1383. http://dx.doi.org/10.1017/S0033291710001935 10.1017/S0033291710001935
- *Lewis-Fernández, R., Balán, I. C., Patel, S. R., Sánchez-Lacay, J. A., Alfonso, C., Gorritz, M., … Moyers, T. B. (2013). Impact of motivational pharmacotherapy on treatment retention among depressed Latinos. Psychiatry: Interpersonal and Biological Processes, 76, 210–222. http://dx.doi.org/10.1521/psyc.2013.76.3.210 10.1521/psyc.2013.76.3.210
- MacPhillamy, D., & Lewinsohn, P. (1982). The pleasant events schedule: Studies on reliability, validity, and scale intercorrelation. Journal of Consulting and Clinical Psychology, 50, 363–380. http://dx.doi.org/10.1037/0022-006X.50.3.363 10.1037/0022-006X.50.3.363
- Majani, G., Callegari, S., Pierobon, A., Giardini, A., Viola, L., Baiardini, I., & Sommaruga, M. (1999). A new instrument in quality-of-life assessment. International Journal of Mental Health, 28, 77–82. http://dx.doi.org/10.1080/00207411.1999.11449463 10.1080/00207411.1999.11449463
- Marcus, S. C., & Olfson, M. (2010). National trends in the treatment for depression from 1998 to 2007. Archives of General Psychiatry, 67, 1265–1273.10.1001/archgenpsychiatry.2010.151
- *McEvoy, P., Burgess, M., & Nathan, P. (2013). The relationship between interpersonal problems, negative cognitions, and outcomes from cognitive behavioral group therapy for depression. Journal of Affective Disorders, 150, 266–275. http://dx.doi.org/10.1016/j.jad.2013.04.005 10.1016/j.jad.2013.04.005
- Merikangas, K. R., Ames, M., Cui, L., Stang, P. E., Ustun, T. B., Von Korff, M., & Kessler, R. C. (2007). The impact of comorbidity of mental and physical conditions on role disability in the US adult household population. Archives of General Psychiatry, 64, 1180–1188. http://dx.doi.org/10.1001/archpsyc.64.10.1180 10.1001/archpsyc.64.10.1180
- Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., … Stewart, L. (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ, 349, 7647. https://doi.org/10.1136/bmj.g7647
- Moons, P., Budts, W., & De Geest, S. (2006). Critique on the conceptualisation of quality of life: A review and evaluation of different conceptual approaches. International Journal of Nursing Studies, 43, 891–901. http://dx.doi.org/10.1016/j.ijnurstu.2006.03.015 10.1016/j.ijnurstu.2006.03.015
- Montgomery, S. A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 322–389. http://dx.doi.org/10.1192/bjp.134.4.382
- *Nicolau, J., Rivera, R., Francés, C., Chacártegui, B., & Masmiquel, L. (2013). Treatment of depression in type 2 diabetic patients: Effects on depressive symptoms, quality of life and metabolic control. Diabetes Research and Clinical Practice, 101, 148–152. http://dx.doi.org/10.1016/j.diabres.2013.05.009 10.1016/j.diabres.2013.05.009
- *Oei, T. P., & McAlinden, N. M. (2014). Changes in quality of life following group CBT for anxiety and depression in a psychiatric outpatient clinic. Psychiatry Research, 220, 1012–1018. http://dx.doi.org/10.1016/j.psychres.2014.08.036 10.1016/j.psychres.2014.08.036
- Orjuela-Rojas, J. M., Martínez-Juárez, I. E., Ruiz-Chow, A., & Crail-Melendez, D. (2015). Treatment of depression in patients with temporal lobe epilepsy: A pilot study of cognitive behavioral therapy vs. selective serotonin reuptake inhibitors. Epilepsy & Behavior, 51, 176–181. http://dx.doi.org/10.1016/j.yebeh.2015.07.033 10.1016/j.yebeh.2015.07.033
- *Paile-Hyvärinen, M., Wahlbeck, K., & Eriksson, J. G. (2003). Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: A single-blind randomised placebo controlled trial. BMC Family Practice, 4, 1–6. http://dx.doi.org/10.1186/1471-2296-4-7
- *Parker, G., Blanch, B., Paterson, A., Hadzi-Pavlovic, D., Sheppard, E., Manicavasagar, V., … Perich, T. (2013). The superiority of antidepressant medication to cognitive behavior therapy in melancholic depressed patients: A 12-week single-blind randomized study. Acta Psychiatry Scandanavica, 128, 271–281. http://dx.doi.org/10.1111/acps.12049
- *Peveler, R., Kendrick, T., Buxton, M., Longworth, L., Baldwin, D., Moore, M., & Thomson, C. (2005). A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine. Health Technology Assessment, 9, 1–134.
- *Qiu, J., Chen, W., Gao, X., Xu, Y., Tong, H., Yang, M., … Yang, M. (2013). A randomized controlled trial of group cognitive behavioral therapy for Chinese breast cancer patients with major depression. Journal of Psychosomatic Obstetrics & Gynecology, 34, 60–67. http://dx.doi.org/10.3109/0167482X.2013.766791 10.3109/0167482X.2013.766791
- *Rabkin, J. G., Wagner, G., & Rabkin, R. (1994). Effects of sertraline on mood and immune status in patients with major depression and HIV illness: An open trial. Journal of Clinical Psychiatry, 55, 433–339.
- Radloff, L. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401. http://dx.doi.org/10.1177/014662167700100306 10.1177/014662167700100306
- Revicki, D., Turner, R., Brown, R., & Martindale, J. (1992). Reliability and validity of a health-related quality of life battery for evaluating outpatient antidepressant treatment. Quality of Life Research, 1, 257–266. http://dx.doi.org/10.1007/BF00435635 10.1007/BF00435635
- *Richards, D. A., Ekers, D., McMillan, D., Taylor, R. S., Byford, S., Warren, F. C., … O’Mahen, H. (2016). Cost and outcome of behavioural activation versus cognitive behavioural therapy for depression (COBRA): A randomised, controlled, non-inferiority trial. The Lancet, 388, 871–880. http://dx.doi.org/10.1016/S0140-6736(16)31140-0 10.1016/S0140-6736(16)31140-0
- Robertson, C., Ramsay, C., Gurung, T., Mowatt, G., Pickard, R., & Sharma, P. (2015). Practicalities of using a modified version of the Cochrane Collaboration risk of bias tool for randomised and non-randomised study designs applied in a health technology assessment setting. Research Synthesis Methods, 5, 200–211. http://dx.doi.org/10.1002/jrsm.110
- Rosenthal, R. (1984). Meta-analytic procedures for social research. Thousand Oaks, CA: Sage.
- Rosenthal, R. (1991). Meta-analytic procedures for social research (Revised ed.). Thousand Oaks, CA: Sage.10.4135/9781412984997
- Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., … Keller, M. D. (2003). The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54, 573–583. http://dx.doi.org/10.1016/S0006-3223(02)01866-8 10.1016/S0006-3223(02)01866-8
- *Saulsman, L., Coall, D., & Nathan, P. (2006). The association between depressive personality and treatment outcome for depression following a group cognitive-behavioral intervention. Journal of Clinical Psychology, 62, 1181–1196. http://dx.doi.org/10.1002/(ISSN)1097-4679 10.1002/(ISSN)1097-4679
- *Saveanu, R., Etkin, A., Duchemin, A. M., Goldstein-Piekarski, A., Gyurak, A., Debattista, C., … Williams, L. M. (2015). The international study to predict optimized treatment in depression (iSPOT-D): Outcomes from the acute phase of antidepressant treatment. Journal of Psychiatric Research, 61, 1–12. http://dx.doi.org/10.1016/j.jpsychires.2014.12.018 10.1016/j.jpsychires.2014.12.018
- *Shelton, R. C., Haman, K. L., Rapaport, M. H., Kiev, A., Smith, W. T., Hirschfeld, R. M., … Dunner, D. L. (2006). A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder. The Journal of Clinical Psychiatry, 67, 1674–1681. http://dx.doi.org/10.4088/JCP.v67n1102 10.4088/JCP.v67n1102
- Sinha, Y., Craig, J., Sureshkumar, P., Hayen, A., & Brien, J. (2015). Risk of bias in randomized trials of pharmacological interventions in children and adults. Journal of Pediatrics, 165, 367–371. http://dx.doi.org/10.1016/j.jpeds.2014.03.058
- Smith, K., Avis, N., & Assmann, S. (1999). Distinguishing between quality of life and health status in quality of life research: A meta-analysis. Quality of Life Research, 8, 447–459. http://dx.doi.org/10.1023/A:1008928518577
- Spielmans, G. I., Berman, M. I., Linardatos, E., Rosenlicht, N. Z., Perry, A., & Tsai, A. C. (2013). Adjunctive atypical antipsychotic treatment for major depressive disorder: A meta-analysis of depression, quality of life, and safety outcomes. PLOS Medicine, 10, e1001403. http://dx.doi.org/10.1371/journal.pmed.1001403
- Spielmans, G. I., & Gerwig, K. (2014). The efficacy of antidepressants on overall well-being and self-reported depression symptom severity in youth: A meta-analysis. Psychotherapy and Psychosomatics, 83, 158–164. http://dx.doi.org/10.1159/000356191
- Spitzer, W. O., Dobson, A. J., Hall, J., Chesterman, E., Levi, J., Shepherd, R., … Catchlove, B. R. (1981). Measuring the quality of life of cancer patients. Journal of Chronic Diseases, 34, 585–597. http://dx.doi.org/10.1016/0021-9681(81)90058-8 10.1016/0021-9681(81)90058-8
- *Swan, A., Watson, H., & Nathan, P. (2009). Quality of life in depression: An important outcome measure in an outpatient cognitive-behavioural therapy group programme? Clinical Psychology & Psychotherapy, 16, 485–496. http://dx.doi.org/10.1002/cpp.588 10.1002/cpp.588
- Trivedi, M. H., Pigotti, T. A., Perera, P., Dillingham, K. E., Carfagno, M. L., & Pitts, C. D. (2004). Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder. The Journal of Clinical Psychiatry, 65, 1356–1364.
- Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Warden, D., McKinney, W., Downing, M., … Sakeim, H. A. (2006). Factors associated with health-related quality of life among outpatients with major depressive disorder. The Journal of Clinical Psychiatry, 67, 185–195. http://dx.doi.org/10.4088/JCP.v67n0203 10.4088/JCP.v67n0203
- *Vilhauer, J., Cortes, J., Moali, N., Chung, S., Mirocha, J., & Ishak, W. (2013). Improving quality of life for patients with major depressive disorder by increasing hope and positive expectations with future directed therapy (FDT). Innovative Clinical Neuroscience, 10, 12–22.
- Wang, C. H., Zhang, D. M., & Tang, X. L. (2003). The standardization of Chinese version of functional assessment of cancer therapy – Breast (FACT-B). Chinese Mental Health Journal, 17, 298–300.
- Ware, J., & Sherbourne, C. (1992). The MOS 36-ltem Short-Form Health Survey (SF-36). Medical Care, 30, 473–483. http://dx.doi.org/10.1097/00005650-199206000-00002 10.1097/00005650-199206000-00002
- *Watson, H., & Nathan, P. (2008). Role of gender in depressive disorder outcome for individual and group cognitive-behavioral treatment. Journal of Clinical Psychology, 64, 1323–1337. http://dx.doi.org/10.1002/jclp.v64:12 10.1002/jclp.v64:12
- World Health Organization. (1995). The World Health Organization quality of life assessment (WHOQOL): Position paper from the World Health Organization. Social Science & Medicine, 41, 1403–1409. http://dx.doi.org/10.1016/0277-9536(95)00112-K
- World Health Organization. (2005). The global burden of disease: 2004 update. Retrieved from http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/
- Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67, 361–370. http://dx.doi.org/10.1111/acp.1983.67.issue-6 10.1111/acp.1983.67.issue-6
- Zung, W. (1965). A self-rating depression scale. Archives of General Psychiatry, 12, 63–70. http://dx.doi.org/10.1001/archpsyc.1965.01720310065008 10.1001/archpsyc.1965.01720310065008